We can observe that the total tau protein levels do not show evidence of differences in the concentrations of the three age groups of patients; that is, in patients with and without AD, total tau protein does not appear to be a probable biomarker to aid in the diagnosis of the disease. The gene discussed is MAPT; the disease is Alzheimer disease.